Dr Marta Monjo Cabrer Appointed Scientific Deputy Director of IdISBa
The Board of Trustees of the Health Research Institute of the Balearic Islands (IdISBa) has approved the appointment of Dr Marta Monjo Cabrer as the Institute's new Scientific Deputy Director for a four-year term. Dr Monjo succeeds Dr Julia García Fuster, who has held this position over recent years.
Dr Marta Monjo Cabrer is a Professor of Biochemistry and Molecular Biology at the University of the Balearic Islands (UIB) and a leading researcher in the fields of regenerative medicine and tissue engineering. She holds degrees in Biology and Biochemistry from the UIB and earned her PhD from the same university in 2004 after completing predoctoral training and research stays at the University of Oslo (Norway), where she later also carried out her postdoctoral research. She was a Ramón y Cajal Research Fellow from 2009 to 2013 and has been carrying out her teaching and research duties at the UIB since 2014, where she currently holds a full professorship. She co-leads the TERCIT research group (Cell Therapy and Tissue Engineering), affiliated with the UIB, IUNICS and IdISBa, and coordinates the PhD programme in Translational Research in Public Health and Highly Prevalent Diseases. Her scientific work focuses on the development of novel biomaterials, advanced therapies and specialised medical products. She has an outstanding track record in knowledge transfer and innovation, reflected in more than one hundred scientific publications and several patents.
Within IdISBa, Dr Monjo has held several positions of scientific responsibility. She currently serves as the representative of the Cross-cutting Area of Health Science and Technology on the Internal Scientific Committee and is a member of the Institute's Innovation Committee, where she has actively contributed to shaping the institution's strategic research and innovation priorities.
With this appointment, IdISBa strengthens its commitment to scientific excellence, innovation and the promotion of translational research by incorporating into its scientific leadership a researcher with a solid academic background and extensive experience in scientific leadership.